Summary: This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization.
Summary: In this webinar a group of experienced cancer drug developers discusses key strategies in managing an orphan drug program.
Summary: This webinar discusses, key considerations of early drug development, molecule developability assessment, drug bioavailability and discussed the relationship between intracellular and transcellular permeability of beyond the Rule of Five drugs.
Summary: A growing number of drug launches have faltered at the final hour because manufacturing processes weren’t up to FDA standards. This webinar explores how drug developers can properly monitor quality throughout the clinical production process and fix any issues that arise—before the FDA brings out the red flags.
Summary: This webinar provides an introduction and comparison of top-spray and bottom-spray fluid bed coating technologies and how to select the most appropriate technique to meet the target product profile.
